PepGen (PEPG) Total Current Liabilities (2021 - 2026)
PepGen (PEPG) posted Total Current Liabilities of $9.0 million for Q1 2026, down 29.12% sequentially from $12.6 million in Q4 2025, and down 56.13% YoY from $20.4 million in Q1 2025.
Analysis
PepGen (PEPG) Total Current Liabilities (2021 - 2026) Analysis & Trends
PepGen has reported Total Current Liabilities for 6 years, with the latest figure at $9.0 million in Q1 2026.
- Quarterly Total Current Liabilities fell 56.13% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 million (down 56.13% YoY) and the FY2025 annual result came in at $12.6 million, down 24.26% from the prior year.
- Total Current Liabilities fell to $9.0 million in Q1 2026 per PEPG's latest filing, from $12.6 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $22.1 million in Q2 2024 and troughed at $9.0 million in Q1 2026.
- A 5-year average of $16.6 million and a median of $16.8 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Current Liabilities jumped 82.42% in 2022, then sank 56.13% in 2026.
- Over 5 years, Total Current Liabilities stood at $18.8 million in 2022, then dropped by 6.89% to $17.5 million in 2023, then retreated by 4.76% to $16.7 million in 2024, then dropped by 24.26% to $12.6 million in 2025, then dropped by 29.12% to $9.0 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $9.0 million, $12.6 million, and $12.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.53 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 354.06 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 630.93 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 438.74 Mn |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - | 9.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.01 Mn |
| Mar 31, 2026 | 8.96 Mn |
| Dec 31, 2025 | 12.65 Mn |
| Sep 30, 2025 | 12.64 Mn |
| Jun 30, 2025 | 16.36 Mn |
| Mar 31, 2025 | 20.43 Mn |
| Dec 31, 2024 | 16.70 Mn |
| Sep 30, 2024 | 16.81 Mn |
| Jun 30, 2024 | 22.11 Mn |
| Mar 31, 2024 | 11.26 Mn |
| Dec 31, 2023 | 17.53 Mn |
| Sep 30, 2023 | 20.96 Mn |
| Jun 30, 2023 | 16.94 Mn |
| Mar 31, 2023 | 18.03 Mn |
| Dec 31, 2022 | 18.83 Mn |
| Sep 30, 2022 | 15.52 Mn |
| Jun 30, 2022 | 20.58 Mn |
| Mar 31, 2022 | 16.12 Mn |
| Dec 31, 2021 | 10.32 Mn |